begin{tabular}{|l|c|c|c|c|} hline ANTIDIABETIC MEDICATION COMPARISON TABLE: & Indications & Major Adverse effects & \ hline begin{tabular}{l} Pharm class \ Prototype drug \ Route end{tabular} & begin{tabular}{c} Mechanism of \ Action end{tabular} & Contraindications \ hline begin{tabular}{l} Parenteral Insulin \ aspart (NovoLog) \ lispro (Humalog) SUBQ \ glargine (Lantus) SUBQ end{tabular} & & & & \ hline begin{tabular}{l} Biguanides \ metformin (Glucophage) \ metformin ER (Glucophage \ ER) \ PO end{tabular} & & & & \ hline begin{tabular}{l} Gliptins, DPP4 inhibitor \ sitagliptin (Januvia) \ PO end{tabular} & & & & \ hline begin{tabular}{l} GLP1 Receptor Agonists (an \ incretin subclass) end{tabular} & & & & \ hline begin{tabular}{l} semaglutide (Ozempic, \ Wegovy) \ SUBQ (1 PO semaglutide too) end{tabular} & & & & \ hline begin{tabular}{l} SGLT2 inhibitor \ canagliflozin (Invokana) \ PO end{tabular} & & & & \ hline begin{tabular}{l} Sulfonylureas \ glyburide (DiaBeta, Glynase) \ PO end{tabular} & & & & \ hline end{tabular}
[Solved]: begin{tabular}{|l|c|c|c|c|} hline ANTIDIABETIC…
Need help with your Endocrine & Metabolic Disorders case study or NCLEX preparation? Connect with a verified Nursing expert now.